1,060
Views
4
CrossRef citations to date
0
Altmetric
Oncology

Healthcare and economic burden of adverse events among patients with chronic myelogenous leukemia treated with BCR-ABL1 tyrosine kinase inhibitors

, , &
Pages 687-691 | Received 01 Feb 2017, Accepted 28 Feb 2017, Published online: 12 Mar 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ahmet Emre Eskazan. (2018) The issue of financial toxicity in the management of chronic myeloid leukemia with blast crisis. Journal of Medical Economics 21:7, pages 709-711.
Read now

Articles from other publishers (3)

Fangting Chen, Wendong Yao, Fan Wu, Rui Xie, Jianping Wang & Zheng Shi. (2022) The status of TKI/acid-suppressant concomitant use in 44 hospitals in China: A cross-sectional descriptive study. Medicine 101:46, pages e31770.
Crossref
Benyam Muluneh, Rena M. Conti, Joehl Nguyen, Ashley Cole, Richard A. Larson & Stacie B. Dusetzina. 2021. Chronic Myeloid Leukemia. Chronic Myeloid Leukemia 93 104 .
Seth M. Cohen, Hui‐Jie Lee, David A. Leiman, Nelson Roy & Stephanie Misono. (2018) Associations between Community‐Acquired Pneumonia and Proton Pump Inhibitors in the Laryngeal/Voice‐Disordered Population. Otolaryngology–Head and Neck Surgery 160:3, pages 519-525.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.